Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- age ≤4 years
- abdominal distension
- abdominal mass
- pain
- decreased appetite
- weight loss
- fussiness (infants)
- fatigue
- periorbital ecchymosis (raccoon eyes)
- subcutaneous skin nodules
- family history of neuroblastic tumors
- signs of spinal cord compression
- signs of Horner syndrome
- signs of superior vena cava syndrome
- intractable secretory diarrhea
- opsoclonus-myoclonus ataxia (OMA)
Otros factores de diagnóstico
- constipation
- pallor
- bleeding
- infections
- hypertension
- hepatomegaly
Factores de riesgo
- neurocristopathies or other syndromes
- family history of neuroblastic tumors or genetic predisposition
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- CBC
- serum electrolytes
- serum creatinine/BUN
- LFTs
- urine catecholamines
- ultrasound abdomen
- CT scan
- MRI scan
- tumor biopsy
Pruebas diagnósticas que deben considerarse
- bilateral bone marrow aspiration and biopsy
- molecular genetic testing
- serum LDH
- serum vasoactive intestinal peptide (VIP)
- 123-iodine-metaiodobenzylguanidine (MIBG) scintigraphy
- positron emission tomography with 18-F-deoxyglucose (18F-FDG PET)
Algoritmo de tratamiento
low-risk disease
intermediate-risk disease
high-risk disease
relapsed or refractory disease
Colaboradores
Autores
Jason Shohet, MD, PhD
Associate Professor
University of Massachusetts
Chan Medical School
Worcester
MA
Divulgaciones
JS is an author of a reference cited in the topic.
Jennifer Foster, MD, MPH
Clinical Director, Neuroblastoma Program
Associate Professor
Department of Pediatrics Section of Hematology/Oncology
Texas Children's Cancer Center
Baylor College of Medicine
Houston
TX
Divulgaciones
JF has served on the advisory board for US WorldMeds. JF is an author of references cited in the topic.
Revisores por pares
Juliet C Gray, MB, BS, MA, MRCPCH, PhD
Associate Professor and Consultant in Paediatric Oncology
University of Southampton
Southampton
UK
Divulgaciones
JCG declares that she has no competing interests.
Daniel Weiser, MD
Medical Director, Intra-Abdominal Solid Tumor Program
Children's Hospital at Montefiore
Assistant Professor, Departments of Pediatrics & Genetics
Albert Einstein College of Medicine
Bronx
NY
Divulgaciones
DW declares that he has no competing interests.
Keri A. Streby, MD
Assistant Professor of Pediatrics
Nationwide Children's Hospital
The Ohio State University
Columbus
OH
Divulgaciones
KS is a consultant for YmAbs Therapeutics, Inc, Amgen, and Illumina Radiopharmaceuticals, Inc.
David Ziegler, MBBS, BSc (Med), FRACP, MD/PhD
Senior Staff Specialist
Sydney Children’s Hospital
Randwick
Sydney
Australia
Divulgaciones
DZ declares that he has no competing interests.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
Brisse HJ, McCarville MB, Granata C, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology. 2011 Oct;261(1):243-57.Texto completo Resumen
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: neuroblastoma [internet publication].Texto completo
Park JR, Bagatell R, Cohn SL, et al. Revisions to the International Neuroblastoma Response Criteria: a consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2017 Aug 1;35(22):2580-7.Texto completo Resumen
Irwin MS, Naranjo A, Zhang FF, et al. Revised neuroblastoma risk classification system: a report from the Children's Oncology Group. J Clin Oncol. 2021 Oct 10;39(29):3229-41. Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

Diferenciales
- Wilms tumor
- Ewing sarcoma
- Rhabdomyosarcoma
Más DiferencialesGuías de práctica clínica
- NCCN clinical practice guidelines in oncology: neuroblastoma
- Revisions to the International Neuroblastoma Response Criteria
Más Guías de práctica clínicaInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad